# Evaluation of The Effect of Rutin and Vitamin C on the Oxidative Stress in Hemodialysis Patients

Study · id `cardio:ct-nct04955145` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT04955145](<https://clinicaltrials.gov/study/NCT04955145>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT04955145

Browse, organ or system: Kidneys  
Browse, condition area: Kidney connections  

## In plain language

A phase 3 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 105 participants.

## Technical summary

Registry record NCT04955145. Randomized; no masking; primary purpose treatment. Start 2021-06-20 (actual); primary completion 2022-01 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Phase 3
- Enrolled: 105 participants (planned count; ClinicalTrials.gov record NCT04955145, source copy `cardio:ctgov-nct04955145-2021-07-19`, retrieved 2026-10-26)
- Started: 2021-06-20 (actual) (ClinicalTrials.gov record NCT04955145, source copy `cardio:ctgov-nct04955145-2021-07-19`, retrieved 2026-10-26)
- Primary completion: 2022-01 (anticipated) (ClinicalTrials.gov record NCT04955145, source copy `cardio:ctgov-nct04955145-2021-07-19`, retrieved 2026-10-26)
- Completion: 2022-02 (anticipated) (ClinicalTrials.gov record NCT04955145, source copy `cardio:ctgov-nct04955145-2021-07-19`, retrieved 2026-10-26)
- Countries: Egypt (ClinicalTrials.gov record NCT04955145, source copy `cardio:ctgov-nct04955145-2021-07-19`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct04955145-2021-07-19`, retrieved 2026-10-26)

## The registry's words

- Brief title: Evaluation of The Effect of Rutin and Vitamin C on the Oxidative Stress in Hemodialysis Patients
- Condition: End Stage Renal Disease
- Intervention (Drug): RUTA C 60
- Lead sponsor: Ain Shams University
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Chronic kidney disease (CKD) (`cardio:chronic-kidney-disease`)
- Registry lists this organization as the lead sponsor: Ain Shams University (`cardio:org-ain-shams-university`)

## Provenance

Content hash: b1b8a23ab496fcebd9a49b3b6db0383854fc5fdfdb85384725ee3af559438ad6
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
